Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian Cancer
Status:
Withdrawn
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as doxorubicin and carboplatin, work in different
ways to stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing. Giving doxorubicin together with carboplatin may kill more tumor cells.
PURPOSE: This phase I and phase II trial is studying the side effects and best dose of
carboplatin when given together with doxorubicin to see how well it works in treating
patients with recurrent ovarian cancer.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Simmons Cancer Center University of Texas Southwestern Medical Center